HAVN Life Sciences Inc. (HAVLF)
HAVN Life Sciences Inc. is a biotechnology firm that specializes in the research and innovation of psychotropic compounds derived from botanical and fungal organisms. The company is also dedicated to establishing standardized, quality-controlled methodologies for extracting these psychoactive molecules, with a specific focus on Psilocybe mushroom species and their key constituents such as psilocybin, psilocin, and baeocystin. Furthermore, it develops natural health products utilizing unregulated ingredients. Founded in 2020, HAVN Life Sciences' operations are headquartered in Richmond, Canada.
Sector: Biotechnology
Industry: Biotechnology
HAVN Life Sciences Inc.
OTC:HAVLFHealthcare · Biotechnology
CLOSED
Mkt Cap-
EV-
Float23.1M
O/S25.65M
VOL116 sh
RVOL1.00×
Inst Own-
Net Cash/Sh-
Dilution
MCap-Float23.1MO/S25.65M
Dilution